资源描述:
《健脾除湿疏利少阳法治疗慢性肾小球肾炎的临床分析》由会员上传分享,免费在线阅读,更多相关内容在工程资料-天天文库。
1、中文摘要试验目的:初步评价健脾除湿、疏利少阳法治疗慢性肾小球肾炎的有效性和安全性。方法:木文通过具有健脾除湿、疏利少阳作用的慢肾安颗粒与肾炎平颗粒进行随机对照临床研究,初步探讨健脾除湿、疏利少阳法治疗慢性肾小球肾炎的有效性和安全性。结果:FAS分析结果表明,慢肾安颗粒试验组对慢性肾小球肾炎的临床控制率为14.0%,控显率为36.4%,总有效率为65.5%;肾炎平颗粒对照组分别为20.0%、40.0%和70.0%,组间比较,差异无统计学意义。慢肾安颗粒试验组对患者脾虚湿盛的愈显率为36.5%,总有效率为84.5%;肾炎平颗粒对照组分别为25.0%和68.4%,组
2、间比较,差异无统计学意义。慢肾安颗粒试验组对患者蛋白尿的临床控制率为15.5%,控显率为41.4%,总有效率为60.3%;肾炎平颗粒对照组分别为25.0%、36.8%和68.4%,组间比较,差异无统计学意义。慢肾安颗粒试验组对患者血尿的临床控制率为34.1%,控显率为34.1%,总有效率为43.2%;肾炎平颗粒对照组分别为45.5%、45.5%和54.5%,组间比较,差异无统计学意义。两组治疗前后均进行了三大常规、肝功、心电图及电解质检查,均未发现与试验药物有关的界常改变,试验过程中未见明显不良反应,安全性较好。结论:健脾除湿、疏利少阳法是治疗慢性肾小球肾炎的
3、有效治法之一,能较好的改善患者的临床症状,减少蛋白尿和血尿,稳定肾功能。关键词:健脾除湿疏利少阳慢性肾小球肾炎中医药疗法临床研究ABSTRACTSObjective:TostudytheeffectandsafetyofTCMtherapy(namedbyreiforcethespleenandtransformingdampness、smoothingandregulatingshao・yang)onchronicglomerulonephritis.Methods:TostudytheeffectandsafetyofTCMtherapy(namedbyr
4、eiforcethespleenandtransformingdampness、smoothingandregulatingshao-yang)onchronicglomerulonephritis.ThestudyadoptsclinicmethodofrandomandcomparisonthroughManshenangranuleandShenyanpinggranulewhichhavethefunctionofreiforcethespleenandtransformingdampness>smoothingandregulatingshao-ya
5、ng.hatconformtotheconditioncanbeselected.Giveingthepationtsmedicineaccordingtosequenceofpatientscomingtohospitalandarrangethepationttothegroupofcureorthegroupofcomparison.TheresultofFASshows:inthegroupofchronicglomerulonephritisthatistreated,therateofcompleteremissionis14.0%,cureand
6、greatefficiencyis36.4%,totalefficiencyis65.5%.inthegroupofcomparison,therateofcompleteremissionis20.0%,cureandgreatefficiencyis40.0%,totalefficiencyis70.0%.Thegroupcomparisonindicates:thecontrasthasnostatisticallysignificant.Inthegroupofdampabundanceduetosplenicastheniathatistreated
7、,therateofcureandgreatefficiencyis36.5%,totalefficiencyis84.5%,inthegroupofcomparison,therateofcureandgreatefficiencyis25.0%,totalefficiencyis68.4%.Thegroupcomparisonindicates:thecontrasthasnostatisticallysignifican匸inthegroupofurineproteinthatistreated,therateofcompleteremissionis1
8、5.5%,cureandgreatef